Summer by Design draws emerging regenerative medicine leaders from around the world to U of T
This month-long series of workshops, lab sessions, tours and conferences aims to advance knowledge and skills required to commercialize new therapies.
Tissue engineering pioneer Michael Sefton to lead Medicine by Design as executive director
Sefton, who also heads a collaborative team project focused on using novel biomaterials to stimulate skeletal muscle to repair itself, begins his five-year term on July 1, 2017.
Multidisciplinary research teams target blindness and stroke damage using regenerative medicine
Read about three Medicine by Design-funded team projects that are unlocking the power of stem cells to better understand and treat neurological diseases.
Medicine by Design pushes frontiers of stem cell research with $1.8 million investment in new tools and devices and in emerging researchers
Six innovative projects investigating the application of new tools and devices to regenerative medicine and four outstanding post-doctoral fellows receive awards.
Medicine by Design invests in next generation of regenerative medicine leaders
Meet the latest recipients of Medicine by Design's Post-Doctoral Fellowship Awards.
Medicine by Design and OIRM invest $1.2 million in technologies and research to advance innovation in regenerative medicine
Twelve targeted projects and two post-doctoral fellowships that are expanding the frontiers of stem cell research will share $1.2 million in funding thanks to programs supported jointly by the University of Toronto’s Medicine by Design initiative and the Ontario Institute for Regenerative Medicine.
Novel imaging techniques could enable new regenerative medicine therapies for lung disease
Giles Santyr is testing whether novel imaging approaches can be used to track where stem cells go when they are introduced into the lungs and what happens to them when they get there.
Tissue culture platform could offer new insights into Duchenne muscular dystrophy
Penney Gilbert hopes to gain new insights into Duchenne muscular dystrophy using a new, three-dimensional tissue culture platform that can grow innervated human muscle in the lab more quickly and efficiently than previous methods.
U of T research helps pave the way for an off-the-shelf supply of cells for immunotherapy
Researchers from Peter Zandstra's lab have developed new technologies that clear key barriers to developing a renewable source of cells for therapies.
Cell transplantation workshop explores continuum from basic science to translation
Nearly 100 researchers, post-doctoral fellows, graduate students and bioscience industry representatives gathered at Hart House on March 10 to discuss cell transplantation in regenerative medicine, from basic science to translation.
Medicine by Design joins regenerative medicine leaders across Canada to form new alliance
Medicine by Design has joined stem cell and regenerative medicine leaders across the country to create the Regenerative Medicine Alliance of Canada, an organization that will support strategic activity and collaboration across the field.
CCRM workshop shines spotlight on regenerative medicine commercialization process
A team from CCRM held a commercialization workshop on March 2 aimed at helping members of the Medicine by Design community take their discoveries from the laboratory to the market.
Collaboration brings together MBA and PhD students to map regenerative medicine ecosystem
A unique collaboration between the Rotman School of Management and Medicine by Design has brought together MBA candidates and PhD students in health sciences and engineering to map the global ecosystem for regenerative medicine.
Medicine by Design partners with XOR, BlueRock to accelerate clinical and commercial programs
A technology that could increase the number of lungs available for transplantation and a stem-cell based treatment that has the potential to reverse heart failure are both a step closer to reality after winning Medicine by Design Clinical Translation and Commercialization Awards.
Gut-on-a-chip offers new way to study intestinal diseases and test treatments
A thumb-sized silicone polymer chip that can mimic the complexity of the human gut may hold the key to understanding inflammatory bowel disease and offer better ways to test new drugs, a University of Texas at Austin researcher said at the inaugural Medicine by Design Speaker Series talk.